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EMIGRATION of leukocytes from the circulation into
tissue by transendothelial migration, is mediated
subsequently by adhesion molecules such as
selectins, chemokines and integrins. This multi-
step paradigm, with multiple molecular choices at
each step, provides a diversity in signals. The
in ux of neutrophils, monocytes and lympho-
cytes into in amed tissue is important in the
pathogenesis of chronic in ammatory bowel dis-
ease. The importance of each of these groups
of adhesion molecules in chronic in ammatory
bowel disease, either in human disease or in
animal models, will be discussed below. Further-
more, the possibilities of blocking these different
steps in the process of leukocyte ex travasation in
an attempt to prevent further tissue damage, will
be taken into account.
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Introduction
Leukocyte migration into inamed tissue is
mediated by different groups of adhesion mole-
cules, present on both the endothelial cells and
on the leukocytes. This allows tissue-speci c
leukocyte ± endothelial interactions, necessary
for efcient surveillance of tissues for infectious
pathogens. However, in case of a chronic
inammatory reaction, the accumulation of
leukocytes is not the result of an adequate
reaction to a pathogenic micro-organism. It is
the result of an unbalanced reaction that leads
to tissue damage and disease, such as chronic
inammatory bowel disease (IBD).
IBD consists of two major illnesses, ulcerative
colitis (UC) and Crohn’s disease (CD). These are
chronic inammatory disorders of the intestine
of unknown origin. Both diseases primarily
affect young adults, but they may present at all
ages. In both diseases the inammatory lesions
are localized in the intestine. Both CD and UC
exhibit features of chronic in ammation, with
prolonged clinical courses and in ammatory
in ltrates consisting of lymphocytes and macro-
phages. However, both diseases also exhibit an
acute component, marked by a constant ow of
neutrophils out of the circulation into the
inamed mucosa, through the epithelium and
into the intestinal lumen.
Despite the fact that the aetiology of IBD
remains unclear, advances in research have
identied immunological, genetic and environ-
mental factors that could play a role in the
aetiology and pathogenesis of these entities. To
obtain more insight into the pathogenesis of
IBD, animal models are required. An ideal model
would be comparable with human disease in
pathogenesis, histopathology, and it should
respond in a similar way to well-tested thera-
peutics as human disease. In this sense, neither
of the currently available models are ideal for
human IBD, yet they can provide useful infor-
mation about the contribution of the different
components of the immune system during
intestinal inammation. They are particularly
useful in studying early inammatory events,
and in the identication of immunologic pro-
cesses and genes that determine susceptibility.
Currently the most widely used model is the
one originally described by Morris et al.1 In this
animal model, colitis is being induced in mice,
rat or rabbits by intracolonic administration of
the contact sensitizing hapten trinitrobenzene
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sulphonic acid (TNBS), dissolved in ethanol.
The ethanol is given to break the mucosal
barrier and it allows the hapten to enter the
intestinal wall. Administration of TNBS in etha-
nol results in acute inammation which usually
is transmural. Spontaneous healing occurs in
approximately 8 weeks. Spontaneous relapses, a
characteristic feature in human IBD, are not
observed in this model. Histopathological fea-
tures are discrete patches with acute inamma-
tion and necrosis, followed by a chronic
inammation with a mononuclear cell in ltrate.
TNBS-induced colitis seems to be based on a
classical delayed-type hypersensitivity response
to this hapten. A histopathologic feature of IBD
and TNBS/ethanol induced experimental IBD, is
a dense in ltration of the tissue by neutrophils
and macrophages and, in chronic disease, of
lymphocytes.
In IBD, immunoreactivity in the gut is not an
adequate, protective response to a known
pathogen, but it causes an ongoing inamma-
tory process that causes severe tissue damage
and morbidity. Therefore, blocking the inux of
leukocytes into the intestinal wall may prevent
further tissue destruction. Emigration of leuko-
cytes from the circulation into tissue, by trans-
endothelial migration, is mediated subsequently
by adhesion molecules such as selectins, che-
mokines and integrins.2 This multistep para-
digm, with multiple molecular choices at each
step, provides a diversity in signals.2 The inux
of neutrophils and monocytes into inamed
tissue is important in the pathogenesis of IBD.
The importance of each of these steps in IBD,
either human disease or animal model, and the
possibilities for blocking each particular step,
will be discussed below.
In¯ ux of Leukocytes in Acute,
Chronic and Relapsing
Experimental Colitis
In acute experimental colitis in rats, induced by
an enema of TNBS in ethanol, neutrophils and
macrophages play an important role (Fig. 1)
whereas in the chronic stage of the disease T
cells play a pivotal role (Fig. 2A).3 The recruit-
ment of inammatory cells into the gut wall
probably is secondary to the damage caused by
the ethanol.
At 1 h after administration of a single dose of
TNBS in ethanol in the colon descendens,
oedema and hyperaemia is already present in
the gut wall, as well as small ulcerative areas.
Macroscopical damage scores (Table 1) increase
to a maximum on t 24 h, and gradually
improve after t 72 h. In the mucosa the
percentage of macrophages gradually increases
from 1 h till day 7, whereas mucosal neutrophils
showed only a slight increase. However, in the
submucosa a striking increase of macrophages
is found at 24 h and neutrophils show the
highest numbers at 72 h (personal observation).
During this very acute stage of the inammatory
reaction, no signi cant differences were found
between rats that were treated with ethanol
alone or TNBS in ethanol. These data illustrate
that in this model macrophages are the  rst
leukocytes that migrate into the already da-
maged gut wall, prior to the increase of neutro-
phils, and are probably responsible for the
increased macroscopical damage score at
FIG. 1. After induction of colitis by a single enema with
TNBS dissolved in ethanol, leukocytes were studied using
immunohistochemistry on cryostat sections. (A) Section of
colonic tissue obtained from a healthy control rat. Darkly
stained neutrophils (arrows) are found in low numbers.
M mucosa; S submucosa, L gut lumen. (B) Tissue
section obtained at day 7 after induction of colitis. The
intestinal wall is transmurally in¯ amed, a large ulcer is
present. Many neutrophils are being found. Oedema is seen
as well. U ulcus; L gut lumen; E oedema.
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t 24 h. In another study on early leukocyte
inux in this model no data were obtained on
increase of macrophages.4 After day 14, no
signicant differences are present anymore be-
tween rats that had received only ethanol in the
colon, and healthy control rats. This indicates
that ethanol in itself induces an acute inamma-
tion. In TNBS/ethanol-induced in ammation a
more chronic stage follows after day 14, which
lasts about 8 ± 12 weeks.
Macrophages and dendritic cells play an
important role in active IBD. Large numbers of
macrophages can be detected in the colon of
patients with CD.5,6 Furthermore, differences
are found, not only in number but also in
heterogeneity of macrophage subpopulations
and dendritic cells in colon from IBD patients
compared with healthy controls and compared
with non-IBD intestinal inammation.5,7 After
treatment of the disease the appearances re-
turned to normal, indicating that the changes
seen in macrophage subpopulations in IBD
are not primary to the disease itself.8 Tissue
concentrations of macrophage derived pro-
inammatory cytokines correlate with disease
activity.9
In rat colon, lymphocytes are normally pres-
ent in small numbers, but after TNBS/ethanol
induced colitis a slight increase was found in
the number of B cells and a striking increase
was observed in the number of T cells in the
submucosa, especially between day 14 and day
FIG. 2. T lymphocytes in TNBS/ethanol-induced colitis. (A) In the chronic phase of the disease T cells play a more important
role than in the acute phase. This section shows T cells in a submucosal blood vessel (arrows). Staining with mAb OX19,
recognizing rat T cells. LP lamina propria; C crypts; V vessel; S submucosa. (B) Three days after a transfer of splenic
CD4 cells, obtained from a rat that suffered from TNBS/ethanol-induced colitis, into a naive recipient. Large T cell in® ltrates
are present (asterisks). Note the presence of oedema and the increase of small, black neutrophils (arrows).
Table 1. Macroscopical damage score
0 no damage
1 localized hyperaemia and/or oedema
2 linear ulcer , half of the width of the colon
3 linear ulcer . half of the width of the colon or small
circular ulcer with a diameter , 1 cm
4 2 circular ulcers with a diameter , 1 cm
5 circular ulcer with a diameter between 1 and 2 cm
6 circular ulcer with a diameter . 2 cm
7 circular ulcerative area with a diameter . 4 cm
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28. The importance of T cells in experimental
colitis has been described before by Sartor, who
observed that the chronic stage of peptidogly-
can ± polysaccharide complex (PG-PS)-induced
enterocolitis is T-cell dependent.10
In an attempt to induce a relapse in the
TNBS/ethanol model, a second, extra-intestinal
administration of TNBS (without ethanol) was
given after the initial exposure of the colon to
TNBS/ethanol.3 This resulted in new areas of
ulceration and renewed increase of leukocytes
in the colonic tissue and these data suggest that
the rats had been sensitized by the  rst dose of
TNBS in the colon.
Selectins in In¯ ammatory Bowel
Disease
Selectins are cell adhesion molecules whose
carbohydrate binding domain is involved in
leukocyte adhesion to activated vascular en-
dothelium. They play a pivotal role in the early
steps of the inammatory process mediating the
attachment of  owing leukocytes to the endo-
thelial cells with labile adhesions in the direc-
tion of the blood ow.11 The initial interaction
is represented by physical rolling of the leuko-
cyte along the vessel wall. The loose connection
and disconnection seems to be mediated
through rapid association and dissociation rate
constants.12 The tethering interaction allows the
leukocyte to respond to subsequent signalling
events that induce tight adhesion which is
necessary for transendothelial migration. Once
neutrophils tightly adhere to endothelial cells,
the bound neutrophil mediates the rolling of
newly arriving neutrophils.13 Recently it has
been shown that T lymphocytes as well, after
being bound to endothelial cells, support the
rolling of newly arrived T lymphocytes.14 The
selectin-mediated step, prior to  rm adhesion to
the endothelial cells is a prerequisite for the
subsequent chemoattractant- and integrin-
mediated steps.
Selectins are a family of three proteins. P-
selectin is stored in granules of platelets and
endothelial cells and is expressed on the surface
of these cells within minutes of cellular stimula-
tion. The expression of E-selectin on the surface
of endothelial cells occurs over a period of hours
following cellular activation. L-selectin is consti-
tutively expressed on most lymphocytes and
mediates trafcking from the blood to lympha-
tics via high endothelial venules. Selectins have a
multidomain structure which includes a signal
sequence, transmembrane domain, epidermal
growth factor (EGF)-like domain, a series of
consensus repeats related to complement regula-
tory domains and a carbohydrate-binding (lectin)
domain. It is this latter domain that is respon-
sible for the adhesion function via binding to a
carbohydrate ligand on leukocytes.
An increased expression of P-selectin is pres-
ent on veins, venules and capillaries in highly
inamed gut, without differences between CD
and UC.15 In uninvolved gut, P-selectin expres-
sion was similar to that seen in normal controls,
except for a focal increase of P-selectin in the
vicinity of small lymphocyte aggregates.15 E-
selectin is present in tissue in active CD and UC
as well, sulphasalazine decreased E-selectin ex-
pression.16 As within CD and UC no difference
in soluble E-selectin in the serum was found
between the active and inactive states,17 serum
levels of selectins do not seem to be useful as a
marker for disease activity.
Small synthetic peptides, based on a con-
served region of E-, L- and P-selectins inhibited
neutrophil adhesion and in ltration in vitro and
in vivo.18,19 Selectin-derived peptides were
shown to inhibit leukocyte trafcking into
thioglycollate-treated peritoneum.19 Inhibition
of neutrophil in ltration into IL-1a treated skin
also has been found following treatment with
selectin derived peptides.19 This effect is prob-
ably mediated by blocking the carbohydrate
ligand for selectins of leukocytes.
Based on this study, a seven amino acid
peptide with the sequence YYWIGIR-NH2 (Tyr-
Tyr-Trp-Ile-Gly-Ile-Arg-NH2) has been studied in
TNBS/ethanol induced colitis (personal ob-
servations).20 Treatment with YYWIGIR-NH2,
based on the sequence of the lectin domain of
selectins, has a benecial effect in TNBS/etha-
nol induced colitis in rats provided treatment
takes place during a period of 7 days. The
treatment resulted in a signicant improvement
of macroscopical damage scores (Table 1) with
70%, compared with the saline-treated colitis
rats (Fig. 3). Regarding the histopathology, most
animals had full re-epithelialization after 7 days
of treatment. Administration of the same pep-
tide during 3 days did have a slight improving
effect on macroscopical damage scores but not
on histopathological, microscopical scores. This
means that the actual area of ulceration was
slightly smaller after 3 days of treatment but
that the inamed areas in themselves were as
severely affected as saline-treated rats.
After treatment with YYWIGIR-NH2 for 7 days,
the number of neutrophils in the submucosa
was signicantly reduced. No inuence was
found on macrophages either in the mucosa or
the submucosa of the peptide treated animals.
MPO activity was decreased signicantly in the
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colon of the rats that had been treated with
YYWIGIR-NH2 on day 0 ± 7 after induction of
colitis, in accordance with the decreased num-
bers of neutrophils in the submucosa.
In earlier studies describing the effects of this
peptide on various inammatory conditions, it
was suggested that its anti-inammatory effect
may be mediated by blocking the carbohydrate
ligand for the (endothelial) selectins on the sur-
face of the leukocytes.19 In line with this
hypothesis, YYWIGIR-NH2 may be capable of
blocking the in ltration of circulating neutro-
phils into colonic submucosa. However, mono-
cytes also have carbohydrate ligands to E- and P-
selectin, and yet the number of macrophages
in the inamed colon was not decreased by
YYWIGIR-NH2. In the previous papers studying
selectin-derived peptides, emphasis was put on
the migration of neutrophils and hence no data
are available yet on the effect of the peptides
on the trafcking of other leukocytes, such as
monocytes and lymphocytes. The differential in
effect on the increase of neutrophils and macro-
phages may be due to a difference in afnity of
the carbohydrate selectin-ligand to YYWIGIR-
NH2. It cannot be excluded that higher doses
would result in a decrease of macrophages as
well.
Recently it has been described that whereas
many single amino acid substitutions are toler-
ated in the peptide structure without complete
loss of inhibitory activity, substitutions at some
positions (e.g. the W residue) results in rel-
atively inactive compounds.21 This points at the
importance of these residues in making crit-
ical contacts with the appropriate saccharide
ligand.21
Chemokines in In¯ ammatory
Bowel Disease
Chemoattractants play a pivotal role in the
activation of integrin adhesiveness and in direct-
ing the migration of leukocytes. Leukocytes
move in the direction of the chemoattractant. A
family of chemoattractive cytokines, which is
termed the chemokine family,22 are 70 ± 80
residue polypeptides and have specicity for
leukocyte subsets.23,24 Their ability to attract
and activate leukocytes makes them important
inammatory mediators. All chemokines have
four conserved cysteines, and two subfamilies
have been identied based on a difference in
sequence around two cysteine residues. The
members of these two families differ in their
target cell selectivity. The C-X-C or a chemo-
kines in particular attract neutrophils whereas
the C-C or b chemokines primarily act on
monocytes and T lymphocyte subpopulations.
The speci city of the chemokine subfamilies
seems to be regulated by the expression of their
receptors on the target cells.2 An important
member of the C-X-C subfamily is IL-8; members
of the C-C chemokine subfamily are mono-
cyte-chemoattractant protein 1 (MCP-1) and
RANTES.
Regarding chemokines in IBD, several studies
have focused on IL-8 in intestinal inammation.
Affected colonic mucosa obtained from patients
with active CD or UC contains signicantly
more IL-8 than tissue of controls,25 but also
more IL-8 than patients with inactive disease.26
The production of IL-8 mRNA is restricted to
areas with histological signs of intestinal inam-
mation in IBD but also in non-IBD inam-
mation.27 In IBD, neutrophils and recently
recruited CD14 macrophages are responsible
for the production of IL-8.28 Epithelial cells in
normal and inamed tissue showed neither
mRNA for IL-8 nor protein. IL-8 mRNA was
expressed signicantly more commonly by
macrophages from IBD affected than from
normal mucosa, and IL-8 secretion by IBD but
not normal colon macrophages was augmented
by lipopolysaccharide treatment. These data
suggest a continuous cycle of neutrophil activa-
tion in IBD28 with an important role for bacter-
ial antigens derived from the gut lumen.
Serum IL-8 is enhanced in some IBD patients
groups, but in CD no difference was found
between active and inactive disease.29 These
data suggest that although IL-8 as a local
chemoattractant is involved in the inammatory
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FIG. 3. Treatment of experimental colitis in rats with selec-
tin-derived peptides: in¯ uence on the distribution pattern
of macroscopical damage scores on day 7 after induction.
TNBS/eth rats that only received an enema with TNBS/
ethanol, no further treatment. TNBS Na: rats that were
treated with vehicle, after induction of colitis. TNBS YY:
rats were treated with the selectin-derived peptide YYWIGIR-
NH2 on days 0 ± 7 after induction of colitis.
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process in the intestine, it is a poor marker of
disease activity.29
Regarding the C-C chemokines, MCP-1 is
expressed constitutively in the human intestinal
colonic mucosa and is upregulated during
inammation. In addition to lamina propria
macrophages, endothelial cells and intestinal
epithelial cells are able to produce MCP-1.30 In
another study, MCP-1 gene expression was
restricted to the lamina propria in IBD-patients,
whereas the gene encoding for RANTES was
expressed in intra-epithelial lymphocytes and in
the sub-epithelial lamina propria.31 Compared
with non-inamed controls, in endothelial cells
of venules in IBD an increase of MCP-1 mRNA
and an increase of MCP-1 expressing cells was
observed.31,32 As no increase in mRNA was
found for RANTES in endothelial cells,31 this
suggests a pivotal role for MCP-1 but not for
RANTES in the adhesion of blood monocytes in
IBD.31 RANTES is being produced by T lympho-
cytes and besides monocytes has other T
lymphocytes as its target cells.2 Taken together
with the described epithelia-associated localiza-
tion, this suggests a role for RANTES in direct-
ing local T lymphocytes and monocytes towards
the epithelial layer which is disrupted and
vulnerable to lumenal bacteria in IBD.
In experimentally induced colitis, the  rst
leukocytes that increase signicantly after intra-
colonic administration of TNBS in ethanol
are macrophages, whereas neutrophils do not
increase in number until t 48 h after the
induction of intestinal in ammation (personal
observation). This early involvement of macro-
phages may suggest that upregulation of MCP-1
precedes the production of neutrophil attract-
ing C-X-C chemokines such as IL-8.
Integrins in In¯ ammatory Bowel
Disease
A family of adhesion glycoproteins which med-
iate  rm leukocyte adherence to the vascular
endothelium is the family of the integrins. Each
integrin has a non-covalently associated a and b
subunit. Several integrins are important in the
interaction of leukocytes with endothelial cells
such as the b2-integrins or CD11/CD18. CD11/
CD18 is a heterodimeric complex consisting of
non-covalently associated a and b units. Three
forms of the a component of the adhesion
molecule have been identied: aL (CD11a or
lymphocyte function-associated antigen LFA-1),
aM (CD11b or complement receptor type 3,
CR3) and aX (CD11c). Each a component is
associated with a common b2 subunit CD18.
Two other members of the integrin family share
the same a subunit: the a4-integrins a4b1 (VLA-
4) and a4b7 (LPAM-1).
The b2-integrins are all expressed on mono-
cytes and neutrophils, although a1b2 is also
expressed on lymphocytes. The ligands for
these leukocyte integrins are intercellular adhe-
sion molecules (ICAM)-1,2 and 3. Induction of
ICAM-1 on endothelial cells by pro-inammatory
cytokines may increase leukocyte adhesion and
migration into inammatory sites, whereas the
constitutive expression of ICAM-2 may be im-
portant in leukocyte traf cking in uninamed
sites.2 The a4-integrins are mainly expressed on
B and T lymphocytes, and they all play a role in
adhesion and migration of leukocytes to the
endothelium.2 Vascular cell adhesion molecule
1 (VCAM-1) is a ligand for a4b1. a4b7 is the
receptor for MadCAM-1 which is an adhesion
molecule for lymphocytes that is expressed by
mucosal venules and helps direct lymphatic
trafc into Peyer’s patches and the intestinal
lamina propria. The interaction of a4b7 and
MadCAM-1 plays a role in lymphocyte homing
to mucosal sites.33
Patients with active CD or UC have signi -
cantly higher expression of ICAM-1 on venules34
and higher ICAM-1 in serum as well.35,36 In
several studies it has been shown that mAbs
against adhesion molecules reduce migration of
leukocytes into inammatory sites. Treatment
with mAbs against ICAM-1, started after the
onset of colitis in rats, had a benecial effect.37
mAbs directed against the common b2 compo-
nent of the integrins are capable of preventing
adherence through all three members of the
integrin family. In animal models, anti-CD18 has
been shown to reduce perfusion injury in
various tissues and species.38 40 Furthermore,
anti-CD18 reduced indomethacine-induced gas-
tropathy41 and TNBS/ethanol induced experi-
mental colitis in rabbits.42 Treatment of TNBS/
ethanol-induced colitis with anti-CD11b/CD18
mAbs results in reduced inux of neutrophils
and macrophages into the colon, which was
shown by histology and by reduced MPO
activity.43 In the latter study, levels of MPO
activity were lower than was to be expected
based upon the reduced numbers of inamma-
tory cells: this reduction was 50 ± 85%, whereas
the MPO activity was almost absent. This might
be explained by the fact that anti-CD11b/CD18
mAbs not only reduce migration of inamma-
tory cells but also inuence phagocyte func-
tions that are thought to play a role in
inammation. CD11/CD18 integrins are re-
quired for neutrophils to initiate a respiratory
burst in response to soluble cytokines.
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T Lymphocyte Migration in
Intestinal In¯ ammation
In rodents and rabbits, administration of TNBS
in ethanol results in an acute colonic inamma-
tion.1 From 2 ± 4 weeks after the induction of
colitis an increase in the number of T cells is
observed in the colon (Fig. 2A). The importance
of T cells in this model was shown by Selve and
Wohrmann44 who described the sensitization of
rats by an intradermal injection of TNBS, prior
to application of TNBS/ethanol to the colon,
resulting in a more severe inammation when
TNBS/ethanol was given. Furthermore, it is also
possible to induce tolerance prior to the appli-
cation of TNBS/ethanol in the colon, resulting
in a reduced inammation.45 These results show
that the chronic inammation is not based on a
non-speci c immune response, in contrast to
the acute phase.
It has been suggested that TNBS/ethanol-
induced colitis in mice is mediated by a Th1
response, since the production of IFNc and IL-2
were upregulated in lamina propria CD4 cells
obtained from these mice.46 This Th1 cytokine
pattern is also found in other animal models.9
Evidence is accumulating in favour of a Th1-like
response in Crohn’s disease.47
Relapses are an important feature of human
disease in IBD. In the TNBS/ethanol model
spontaneous relapses do not occur, but it is
possible to induce relapses by a single or multi-
ple extra-intestinal boosters of TNBS.3,48 To
further elucidate the role of T cells in this
model, splenic T cells from colitis rats were
transferred to naive recipients.49 Transfer of
CD4 T cells to naive recipients results in
migration of the transferred cells to all lymphoid
organs, but in particular to the colonic submu-
cosa on day 1 ± 2 after the transfer. These data
suggest that the T cells that migrate to the
colon are memory T cells that had been
sensitized before in the donor colon following
the TNBS/ethanol application. At subsequent
days also recipients’ own T cells migrate to the
colon, and neutrophils and macrophages also
increase in the colonic submucosa (Fig. 2B).
These cells probably are directed to the colon
by cytokine/chemokine signals that are either
produced or induced by the T cells. There are
several ways to explain the migration of mem-
ory T cells to the colon. Firstly, there might be a
difference in expression of adhesion molecules
and chemokines, such as RANTES that in
particular attracts memory T lymphocytes,50
between colon and other tissues including the
small bowel, although there is no proof of such
a difference within the intestinal tract yet.
Secondly, the transferred T cells might recog-
nize a colon-speci c hapten-modied self-anti-
gen. Another explanation is that the transferred
T cells recognize a component of the recipients
bacterial ora in the intestine. It has been
suggested that, even in healthy immunocompe-
tent hosts, indigenous bacteria are continuously
translocating in low numbers from the luminal
side to the gut tissue, mesenteric lymph nodes
and other extra-intestinal organs.51 Under phy-
siological conditions the translocated bacteria
are engulfed and killed by macrophages in the
colonic tissue and in the lymph nodes. In case
of enhanced bacterial translocation and an
impaired immune reactivity this will lead to
further passage from mesenteric lymph nodes
to liver, spleen, kidney, peritoneal cavity and
the blood. Eventually this may lead to sepsis.52
Upon induction of colitis, T cells may be
sensitized by bacterial components. Transfer of
these T cells to recipients may result in recogni-
tion of similar bacterial components43 since
there is always some translocation into the
intestinal wall.51
Migration of lymphocytes into the gut is also
mediated by sequential groups of adhesion
molecules, with selectin- and integrin-mediated
steps. Lymphocytes that interact with vascular
selectins represent distinct subsets. Certain
memory T cells bind and roll on E-selectin.53,54
Both E- and P-selectin support rolling inter-
actions of bovine cd T cells under physiologic
ow.55 cd lymphocytes, bound to an endothelial
cell monolayer, support rolling of other lympho-
cytes. Anti-L-selectin mAbs block this inter-
action.14
However, lymphocyte homing to the inamed
gut seems to be regulated differently from
lymphocyte homing into non-inamed gut
tissue. Selective migration of lymphocytes is
mediated by organ-specic binding of lym-
phocytes to high endothelial venules (HEV).
Functionally distinct lymphocyte ± endothelial
recognition systems exist in the mucosa-
associated lymphatic tissues, peripheral lymph
node, synovium, and skin.56 58 A difference in
b7 (Peyer’s patch) speci c antigen was ob-
served between lymphocytes obtained from IBD
patients and healthy controls.59 Moreover, it has
been shown that lamina propria immunoblasts
from normal and inamed gut bind differently
to vascular endothelium.60 Immunoblasts from
the normal gut bound extremely well to muco-
sal HEV but not to peripheral lymph node HEV,
whereas cells obtained from IBD patients also
interacted with peripheral lymph node HEV. In
IBDpatients the peripheral lymph node-specic
endothelial adhesion antigen was aberrantly ex-
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pressed in vessels of the inamed mucosa.60
Therefore, in IBD the selectivity of lympho-
cyte ± endothelial interaction seems to be lost.
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